AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION GRANULES FOR SUSPENSION

국가: 캐나다

언어: 영어

출처: Health Canada

지금 구매하세요

Download 제품 특성 요약 (SPC)
04-07-2014

유효 성분:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE)

제공처:

SIVEM PHARMACEUTICALS ULC

ATC 코드:

J01CA04

INN (국제 이름):

AMOXICILLIN

복용량:

250MG

약제 형태:

GRANULES FOR SUSPENSION

구성:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250MG

관리 경로:

ORAL

패키지 단위:

75/100/150ML

처방전 유형:

Prescription

치료 영역:

AMINOPENICILLINS

제품 요약:

Active ingredient group (AIG) number: 0131314003; AHFS:

승인 상태:

CANCELLED POST MARKET

승인 날짜:

2016-12-14

제품 특성 요약

                                1
PRODUCT MONOGRAPH
PR AMOXICILLIN
AMOXICILLIN CAPSULES
250 MG AND 500 MG AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AMOXICILLIN CHEWABLE TABLETS
125 MG AND 250 MG AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AMOXICILLIN GRANULES FOR ORAL SUSPENSION
125 MG/5ML AND 250 MG/5ML AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AFTER
RECONSTITUTION
AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL
SUSPENSION
125 MG/5ML AND 250 MG/5ML AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AFTER
RECONSTITUTION
Antibiotic
Sivem Pharmaceuticals ULC
4705 Dobrin Street
Saint-Laurent, Quebec
H4R 2P7
Control # 174978
Date of Revision:
July 4, 2014
2
NAME OF DRUG
AMOXICILLIN
(AMOXICILLIN TRIHYDRATE)
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION AND CLINICAL PHARMACOLOGY
AMOXICILLIN (amoxicillin) exerts its bactericidal action by
interfering with bacterial
cell wall synthesis.
COMPARATIVE BIOAVAILABILITY STUDIES - TABLETS
A comparative two-way, single-dose bioavailability study was carried
out in sixteen
healthy, male volunteers on two 250 mg amoxicillin tablet products,
AMOXICILLIN
250 mg and Amoxil 250 mg chewable tablets. The pharmacokinetic data of
fifteen
subjects calculated for the AMOXICILLIN and Amoxil chewable tablet
formulations is
tabulated below:
AMOXICILLIN TRIHYDRATE CHEWABLE TABLETS 250 MG
FROM MEASURED DATA
Geometric Mean
Arithmetic Mean (C.V.%)
PARAMETER
TEST
*
REFERENCE
†
% RATIO OF
GEOMETRIC
MEANS
95%
CONFIDENCE
INTERVAL
AUC
T
(µg*h/mL)
20.3
20.4 (10)
20.5
20.7 (16)
99
91.8 – 108.4
AUC
I
(µg• h/mL)
20.5
20.5 (10)
20.5
20.8 (16)
100
91.8 – 108.5
C
max
(µg/mL)
7.4
7.5 (13)
7.7
8.0 (26)
96
84.8 – 109.1
T
max
§
(h)
1.37 (0.40)
1.43 (0.46)
-
T
1/2
§
(h)
0.95 (0.11)
0.92 (0.09)
-
* AMOXICILLIN
250 mg Chewable Tablet (Sivem Pharmaceuticals ULC)
†
Amoxil® 250 mg Chewable Tablet (purchased in Canada).
§
Expressed as the arithmetic mean (standard deviation) only
3
INDICATIONS AND CLINICAL USE
AMOXICILLIN (amoxicillin) may be indicated in the treatment of
infections due to
susceptible strains of the following micro-organisms: Gram-negative
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

제품 특성 요약 제품 특성 요약 프랑스어 04-07-2014

이 제품과 관련된 검색 알림